Praxis precision medicines to participate in td cowen's 44th annual health care conference

Boston, march 01, 2024 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in the td cowen 44th annual health care conference, taking place in boston from march 4 – 6, 2024. in addition to conducting one-on-one investor meetings, management will participate in a corporate panel discussion.
PRAX Ratings Summary
PRAX Quant Ranking